药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfamethazine
Magnesium glycinate
The risk or severity of adverse effects can be increased when Magnesium glycinate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Sodium fluorophosphate
The risk or severity of adverse effects can be increased when Sodium fluorophosphate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Dipotassium phosphate
The risk or severity of adverse effects can be increased when Dipotassium phosphate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Monopotassium phosphate
The risk or severity of adverse effects can be increased when Monopotassium phosphate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Plantago ovata seed
The risk or severity of adverse effects can be increased when Plantago ovata seed is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Zinc
The risk or severity of adverse effects can be increased when Zinc is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Deacetylbisacodyl
The risk or severity of adverse effects can be increased when Deacetylbisacodyl is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Plecanatide
The risk or severity of adverse effects can be increased when Plecanatide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Linaclotide
The risk or severity of adverse effects can be increased when Linaclotide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Bisoxatin
The risk or severity of adverse effects can be increased when Bisoxatin is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Phenolphthalein
The risk or severity of adverse effects can be increased when Phenolphthalein is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Sodium tartrate
The risk or severity of adverse effects can be increased when Sodium tartrate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Pentaerithrityl
The risk or severity of adverse effects can be increased when Pentaerithrityl is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Magnesium citrate
The risk or severity of adverse effects can be increased when Magnesium citrate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Methylcellulose
The risk or severity of adverse effects can be increased when Methylcellulose is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Docusate
The risk or severity of adverse effects can be increased when Docusate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Mineral oil
The risk or severity of adverse effects can be increased when Mineral oil is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Lactitol
The risk or severity of adverse effects can be increased when Lactitol is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Sennosides
The risk or severity of adverse effects can be increased when Sennosides is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Castor oil
The risk or severity of adverse effects can be increased when Castor oil is combined with Sodium phosphate, monobasic, unspecified form.